---
figid: PMC9413558__ijmsv19p1430g001
pmcid: PMC9413558
image_filename: ijmsv19p1430g001.jpg
figure_link: /pmc/articles/PMC9413558/figure/F1/
number: Figure 1
figure_title: ''
caption: 'FBXO17 had a low expression in the endometrial tumor. Low FBXO17 mRNA expression
  in endometrial cancer from TCGA datasets (A) and Fudan cohort validation (B). (C-D)
  Statistical data and representative IHC of FBXO17 expression in endometrial carcinoma
  and para-carcinoma. (E) Representative IHC of FBXO17 expression in different histology
  grades of endometrial carcinoma. Magnification, ×400 and ×60; scale bar: 200 µm
  and 50 µm. A high expression level of FBXO17 appears as brown particles. Data are
  mean ± SD, * P< 0.05, ** P< 0.01, *** P< 0.001. IHC: immunohistochemistry.'
article_title: FBXO17 Inhibits the Wnt/β-Catenin Pathway and Proliferation of Ishikawa
  Cells.
citation: Zi-Meng Zheng, et al. Int J Med Sci. 2022;19(9):1430-1441.
year: '2022'

doi: 10.7150/ijms.60335
journal_title: International Journal of Medical Sciences
journal_nlm_ta: Int J Med Sci
publisher_name: Ivyspring International Publisher

keywords:
- FBXO17
- endometrial cancer
- Wnt/β-catenin pathway
- malignant progression
- Ishikawa

---
